| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
MiMedx Group (NASDAQ:MDXG) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:06 PM.
Here's what investors need to know about the announcement.
MiMedx Group missed estimated earnings by -43.0%, reporting an EPS of $0.04 versus an estimate of $0.07.
Revenue was up $12.46 million from the same period last year.
Last quarter the company beat on EPS by $0.01 which was followed by a 4.0% increase in the share price the next day.
Here's a look at MiMedx Group's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.04 | -0.02 | -0.09 | -0.04 |
| EPS Actual | 0.05 | 0 | -0.06 | -0.02 |
| Revenue Estimate | 78.12M | 74.83M | 64.15M | 74.53M |
| Revenue Actual | 81.71M | 81.26M | 71.68M | 74.38M |
To track all earnings releases for MiMedx Group visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MDXG
